Study of Radiation Therapy Alone or in Combination with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group [PMID:20980108; NIHMSID250178]

M Machtay;K Bae;B Movsas;R Paulus;EM Gore;R Komaki;K Albain;WT Sause;WJ Curran International Journal Radiation Oncology Biology Physics 82(1):425-434

PMid: PMID20980108 | PMC number: NIHMSID250178

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

W Sause;P Kolesar;S Taylor;D Johnson;R Livingston;R Komaki;B Emami;W Curran, Jr;R Byhardt;A Rashid Dar;A Turrisi, III Chest 117:358-364

Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in RTOG 88-08/ECOG 4588.

R Komaki;CB Scott;WT Sause;DH Johnson;S Taylor IV;JS Lee;B Emami;RW Byhardt;WJ Curran Jr;AR Dar;JD Cox Int J Radiat Oncol Biol Phys 39(3):537-544

Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with hyperfractionated radiotherapy with/without chemotherapy: A multivariate analysis of 682 RTOG Patients.

M Werner-Wasik;C Scott;ML Graham;C Smith;RW Byhardt;M Roach, III;EJ Andras Int J Radiat Oncol Biol Phys 39(2)Suppl:314(#2147)

Response, toxicity, failure patterns and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) and radiation therapy (RT) for locally advanced non-small cell lung carcinoma of the lung (NSCLC).

R Byhardt;C Scott;W Sause;B Emami;R Komaki;B Fisher;J Lee;C Lawton Int J Radiat Oncol Biol Phys 39:195(#120)

Intensified treatment increases survival in patients with non-small cell lung cancer at what place? A quality adjusted survival analysis of radiation therapy oncology group chemoradiation studies.

C Scott;B Movsas;WT Sause;R Byhardt;R Komaki;J Cox;DS Johnson;C Lawton;R Dar;T Wasserman;M Roach;JS Lee;EJ Andras Quality of Life Research 6:718(#345)

Addition of chemotherapy to radiation therapy alter failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials.

JD Cox;CB Scott;B Emami;AH Russell;K Fu;M Parliament;R Komaki;L Gaspar International Association of Lung Cancer 18:126(#491)

Toxicity in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC).

R Byhardt;C Scott;WT Sause;B Emami;R Komaki;B Fisher;J Lee;C Lawton International Association of Lung Cancer 18(1):64(#244)

Response, failure patterns and survival in five radiation therpay oncology group (RTOG) trials of sequential and/or concurrent chemotherpy (CT) radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC).

R Byhardt;P Kolesar;WT Sause;B Emami;R Komaki;B Fisher;J Lee;C Lawton International Association of Lung Cancer 18(1):62(#238)

Induction cisplatin/vinblastine decreased distant metastasis in unresectable squamous cell lung cancer (SCC): Failure patterns.

R Komaki;CB Scott;WT Sause;S Taylor IV;DH Johnson;R Livingston;B Emami;WJ Curran;RW Byhardt;AR Dar;AT Turrisi;JD Cox International Journal of Radiation Oncology Biology Physics 36(1):206(#96)

New Chemotherapy/radiation therapy regimens may improve survival for patients with locally advanced unresectable non-small cell lung cancer.

WJ Curran Working in Oncology - Cope Jan/Feb:10-17

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer.

WT Sause;C Scott;S Taylor;D Johnson;R Livingston;R Komaki;B Emami;WJ Curran;RW Byhardt;AT Turrisi;AR Dar;J D Cox Journal of the National Cancer Institute 87(3):198-205

RTOG 8808 ECOG 4588, Preliminary analysis of a phase III trial in regionally advanced unresectable non-small cell lung cancer with minimum three year follow-up.

WT Sause;C Scott;S Taylor;D Johnson;R Livingston;R Komaki;JD Cox;B Emami;WJ Curran;RW Byhardt;AR Dar;AT Turrisi Int.l Journal of Radation Oncology Biology Phyics 32Suppl:195(#109)

Response to induction chemotherapy does not predict for long term survival among patients with unresected stage III non-small cell lung cancer (NSCLC) receiving sequential chemo-radiation on RTOG 8804 and 8808.

WJ Curran;CB Scott;R Komaki;RW Byhardt;S Taylor;B Emami;CJ Langer;AR Dar;JS Cooper;EJ Andras;WT Sause Int.l Journal of Radiation Oncology Biology Physics 32Suppl:196(#111)

RTOG 8808 ECOG 4588, Preliminary analysis of phase III trial in regionally advanced unresectable non-small cell lung cancer.

W Sause;C Scott;S Taylor;D Johnson;R Livingston;R Komaki;B Emami;W Curran;R Byhardt;B Fisher;A Turrisi Proc of the American Society of Clinical Oncology 13:325(#1072)

RTOG 8808 ECOG 4588, Preliminary analysis of a phse III trial in regionally advanced unresectable non-small cell lung cancer.

W Sause;C Scott;SA Taylor;D Johnson;R Livingston;R Komaki;B Emami;W Curran;R Byhardt;G Fisher;A Turrisi Lung Cancer 11Suppl.1:179(#695)